L01XE Protein kinase inhibitors

RX_L01XE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — L01XE 1 out of 7 registries used, show all original rules.	2363
4. Check minimum number of events Min. number of events 3	2363
5. Include endpoints None	2363
6. Filter based on genotype QC (FinnGen only)	1924

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	RX_L01XE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	L01XE
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to L01XE Protein kinase inhibitors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

ILD medications: nintedanib

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1924	1011	913
Unadjusted period prevalence (%)	0.39	0.36	0.42
Median age at first event (years)	67.59	66.11	69.22

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2002: Matched controls
20020

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

25.9

320.7

228

L01XE01

ATC

[U] imatinib

+∞

309.6

289

189

Kela drug reimbursment

Imatinib

1146.0

308.6

294

L01XE04

ATC

[U] sunitinib

1726.6

308.4

292

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

97.6

307.7

178

L02BA03

ATC

fulvestrant; parenteral

65.7

307.7

253

A03FA01

ATC

metoclopramide; systemic, rectal

10.5

307.7

1328

3165

WF049

NOMESCO Finland

Radiotherapy of metastasis

24.0

307.7

639

383

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

17.6

307.7

278

182

N02AA05

ATC

oxycodone; systemic

7.8

307.7

1139

2886

JN4BD

NOMESCO Finland

Extensive body CT

13.1

307.7

977

1359

1501

Kela drug reimbursment

Palbociclib

196.6

307.7

356

L01EF01

ATC

palbociclib; oral

92.0

307.7

184

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

50.7

307.7

261

130

Kela drug reimbursment

Malignant tumour

18.5

307.7

1072

1173

197

Kela drug reimbursment

Sunitinib

283.1

307.7

331

192

Kela drug reimbursment

Fulvestrant

93.3

307.7

224

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

20.4

307.7

373

222

JN4AD

NOMESCO Finland

Body CT examination

6.3

307.7

740

1709

H02AB02

ATC

dexamethasone; systemic

8.7

307.7

860

1602

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

18.6

307.7

334

213

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

25.9

307.7

694

402

A04AA02

ATC

granisetron; systemic, transdermal

8.2

307.7

504

786

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

12.8

307.7

455

450

394

Kela drug reimbursment

Palbociclib

169.1

307.7

314

Z51.5

ICD-10 Finland

Palliative care

11.2

307.7

856

1248

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

120.6

307.7

619

L01XE33

ATC

[U] palbociclib

4122.9

307.7

354

284

Kela drug reimbursment

Nintedanib and pirfenidone

83.0

307.7

195

KAC10

NOMESCO Finland

Total nephrectomy with capsule

42.8

303.1

183

198

Kela drug reimbursment

Sorafenib

158.6

296.4

147

JN4CD

NOMESCO Finland

Very extensive body CT

10.4

292.2

355

407

356

Kela drug reimbursment

Nintedanib and pirfenidone

63.9

287.3

159

M05BX04

ATC

denosumab; parenteral

7.4

283.3

483

827

A04AA01

ATC

ondansetron; systemic, rectal

6.7

281.3

546

1067

1502

Kela drug reimbursment

Cabozantinib

92.6

279.0

146

WF004

NOMESCO Finland

Palliative radiotherapy

14.8

273.7

256

197

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

27.0

268.9

187

L02BG06

ATC

exemestane; oral

17.1

266.4

228

149

3012

Kela drug reimbursment

Cabozantinib

88.5

266.0

140

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

20.4

260.4

204

111

L01CA04

ATC

vinorelbine; systemic

26.1

259.7

183

322

Kela drug reimbursment

Sunitinib

127.4

259.2

131

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

8.4

249.2

358

503

L01BC06

ATC

capecitabine; oral

8.8

244.2

336

448

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

18.7

219.3

178

104

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.6

218.0

341

525

L03AA02

ATC

filgrastim; parenteral

9.6

216.3

271

320

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

10.6

211.6

245

260

WW500

NOMESCO Finland

Blood transfusion

8.2

207.8

300

421

L01XE31

ATC

[U] nintedanib

+∞

205.9

194

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

13.3

205.1

202

168

115

Kela drug reimbursment

Breast cancer

5.5

198.2

457

1026

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

7.6

196.0

305

465

L01EX09

ATC

nintedanib; oral

66.4

194.8

107

L02BG04

ATC

letrozole; oral

6.0

191.1

385

763

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

6.2

188.4

366

700

159

Kela drug reimbursment

Pazopanib

394.0

182.8

181

L02BA01

ATC

tamoxifen; oral

7.7

181.9

274

402

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

7.9

178.9

263

375

X76

ICPC

Malignant neoplasm breast female

11.6

178.6

191

180

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

15.2

175.7

158

112

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

308.7

168.5

169

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

17.8

167.1

138

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

18.2

166.5

136

176

Kela drug reimbursment

Regorafenib

48.5

166.2

WZC00

NOMESCO Finland

Treatment plan or consultation

3.5

164.2

1168

5720

L03AA13

ATC

pegfilgrastim; parenteral

6.5

160.4

288

507

ZX120

NOMESCO Finland

Intravenous

4.7

159.8

443

1146

158

Kela drug reimbursment

Everolimus

422.4

158.7

157

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.2

158.2

526

1562

L01XE11

ATC

[U] pazopanib

1628.6

154.2

148

L04AX05

ATC

pirfenidone; oral

41.4

150.3

AA1BD

NOMESCO Finland

Extensive CT of head and brain

8.9

149.5

195

240

L01EA01

ATC

imatinib; oral

387.1

146.0

145

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

20.9

145.5

111

HAC20

NOMESCO Finland

Total mastectomy

6.8

143.5

241

395

316

Kela drug reimbursment

Imatinib

1452.5

140.3

135

XW000

NOMESCO Finland

Bone marrow biopsy

6.1

138.8

263

486

WZC30

NOMESCO Finland

Teaching

3.5

138.1

661

2486

L01EX07

ATC

cabozantinib; oral

46.9

137.8

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

7.6

137.1

204

293

A79

ICPC

Malignancy NOS

10.5

135.3

154

158

NK6AN

NOMESCO Finland

Total body bone isotope imaging

7.4

134.2

205

303

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.5

133.9

374

965

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.3

131.7

1420

8479

L01XE05

ATC

[U] sorafenib

456.5

130.5

129

R50.9

ICD-10 Finland

Fever, unspecified

3.5

127.2

558

1973

155

Kela drug reimbursment

Afatinib and gefitinib

1286.1

125.4

121

369

Kela drug reimbursment

Regorafenib

38.1

124.5

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.6

121.0

320

788

L01XE26

ATC

[U] cabozantinib

1229.6

120.1

116

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

117.6

509

1775

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

10.1

116.6

136

144

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

40.3

114.8

XX3DW

NOMESCO Finland

Time consuming IT work

3.6

114.7

459

1520

191

Kela drug reimbursment

Erlotinib

306.5

114.3

115

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.0

114.2

268

597

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

10.2

114.2

132

138

A06AH03

ATC

naloxegol; oral

10.2

114.2

132

138

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

32.9

113.3

L01XE03

ATC

[U] erlotinib

585.1

113.1

111

L01XE23

ATC

[U] dabrafenib

1151.0

112.7

109

L01EX01

ATC

sunitinib; oral

59.1

112.3

ZX090

NOMESCO Finland

Other technic of radiotherapy

6.7

110.9

184

296

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

384.6

110.5

110

L01XE10

ATC

[U] everolimus

+∞

109.4

104

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

29.1

108.9

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

33.5

106.1

U75

ICPC

Malignant neoplasm of kidney

48.4

104.5

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

12.1

101.3

103

1CD02, ,

NOMESCO Finland

13.8

101.2

168

Kela drug reimbursment

Axitinib

1028.6

101.1

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

16.3

100.5

A04AD12

ATC

aprepitant; systemic

8.0

99.7

140

187

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

5.7

99.0

194

367

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.6

98.2

253

606

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.1

98.1

123

143

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

5.7

96.5

190

361

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.5

96.1

143

204

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

20.2

96.0

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

973.5

95.8

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

962.5

94.7

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

4.4

93.5

255

638

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.4

93.1

401

1377

L01XE27

ATC

[U] ibrutinib

940.5

92.6

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

10.2

92.6

106

109

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

8.1

92.5

128

168

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

11.5

91.5

TGC00

NOMESCO Finland

Bronchial lavation

6.6

91.4

154

251

N02AA01

ATC

morphine; systemic, rectal

7.7

90.9

132

183

L01XX05

ATC

hydroxycarbamide; oral

9.7

89.9

107

116

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

4.8

88.5

214

486

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.5

88.2

988

5581

A04AA55

ATC

palonosetron, combinations; systemic

5.3

87.0

186

380

180

Kela drug reimbursment

Interferon alfa

27.6

86.5

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

22.0

86.2

340

Kela drug reimbursment

Everolimus

230.0

86.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.5

85.9

349

1152

390

Kela drug reimbursment

Ibrutinib

157.0

85.8

HA1AA

NOMESCO Finland

X-ray mammography

3.7

85.5

313

965

B01AB05

ATC

enoxaparin; parenteral

2.5

85.4

917

5059

L01XE13

ATC

[U] afatinib

+∞

85.0

L03AB05

ATC

interferon alfa-2b; parenteral

27.9

83.9

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

15.3

83.9

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

6.2

83.2

147

251

L01XE25

ATC

[U] trametinib

+∞

82.9

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

21.3

82.4

J94.8

ICD-10 Finland

Other specified pleural conditions

8.4

81.1

108

135

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.3

81.1

230

591

B01AB10

ATC

tinzaparin; parenteral

3.1

81.0

400

1482

L01EF03

ATC

abemaciclib; oral

48.1

80.3

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

78.7

728

3720

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.5

78.3

307

987

1512

Kela drug reimbursment

Ibrutinib

140.6

76.5

3030

Kela drug reimbursment

Abemaciclib

35.1

75.8

1515, ,

Kela drug reimbursment

35.1

75.8

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

8.2

75.8

103

132

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

11.9

75.2

C50.99

ICD-10 Finland

Breast, unspecified

5.5

74.2

149

287

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

10.9

72.8

ZX050

NOMESCO Finland

Stereotactic radiotherapy

11.4

72.2

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.5

71.1

119

192

L01XE18

ATC

[U] ruxolitinib

712.6

70.5

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

6.6

69.3

115

184

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

69.0

726

3884

JN6AD

NOMESCO Finland

CT of torso and neck

6.9

68.8

109

166

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

6.2

68.7

122

209

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

12.8

68.6

B01AB04

ATC

dalteparin; parenteral

4.1

68.5

204

542

C03CA01

ATC

furosemide; systemic

2.3

67.5

844

4849

L01XE21

ATC

[U] regorafenib

86.6

67.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

67.0

277

917

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

18.7

66.6

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.7

65.8

159

359

361

Kela drug reimbursment

Axitinib

659.1

65.3

A02BC02

ATC

pantoprazole; systemic

2.6

64.5

1609

12214

174

Kela drug reimbursment

Ruxolitinib

173.2

64.4

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

22.9

64.3

D70.82

ICD-10 Finland

Drug-induced neutropenia

7.5

63.9

129

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

12.5

63.5

J01MA12

ATC

levofloxacin; systemic

2.4

63.4

547

2664

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

6.6

63.0

103

162

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.0

62.9

141

299

L01XE17

ATC

[U] axitinib

+∞

61.8

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

7.7

61.4

117

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.1

60.3

131

270

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

97.5

60.2

R84

ICPC

Malignant neoplasm bronchus/lung

18.2

59.5

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

16.5

59.1

H02AB06

ATC

prednisolone; systemic

2.1

58.6

1144

7697

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

11.2

58.3

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

16.9

57.5

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

11.9

56.9

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.9

56.8

315

1229

341

Kela drug reimbursment

Afatinib and gefitinib

+∞

56.5

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

16.4

56.5

L02BG03

ATC

anastrozole; oral

6.7

56.4

141

343

Kela drug reimbursment

Pazopanib

151.9

56.2

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

123.7

56.1

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

123.7

56.1

ZX112

NOMESCO Finland

Subcutaneous

5.5

55.9

111

211

152

Kela drug reimbursment

Nilotinib

563.3

55.9

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.2

55.7

117

234

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.8

55.4

131

290

150

Kela drug reimbursment

Dasatinib

+∞

54.4

374

Kela drug reimbursment

Ruxolitinib

146.6

54.1

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

12.6

54.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.5

53.8

199

611

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

8.5

53.7

L01XX28

ATC

[U] imatinib

+∞

53.4

J01MA14

ATC

moxifloxacin; systemic

2.9

53.0

286

1097

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

13.1

52.1

L01XE07

ATC

[U] lapatinib

181.4

51.1

156

Kela drug reimbursment

Lapatinib

261.8

50.3

L01XE06

ATC

[U] dasatinib

+∞

50.2

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

5.0

49.7

111

234

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

15.0

49.4

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

6.6

49.3

128

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

6.9

49.0

116

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

9.3

48.8

E0000UV, ,

ATC

2.0

48.6

951

6253

M04AA01

ATC

allopurinol; systemic

2.4

47.9

396

1866

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

10.2

47.9

L01XE02

ATC

[U] gefitinib

478.9

47.5

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

5.4

47.1

183

L01EL01

ATC

ibrutinib; oral

128.1

47.0

323

Kela drug reimbursment

Sorafenib

61.6

46.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

46.1

489

2556

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

14.9

46.0

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

14.9

46.0

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

45.7

211

740

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

6.6

44.9

114

B03XA02

ATC

darbepoetin alfa; parenteral

4.8

44.4

103

224

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

44.4

586

3326

GD1AD

NOMESCO Finland

Thorax CT examination

2.9

44.4

223

820

L01EJ01

ATC

ruxolitinib; oral

120.3

43.9

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

6.2

43.6

124

PJA12

NOMESCO Finland

Sentinel node biopsy

2.7

43.6

255

1016

9961/3-C42.1

ICD-O-3

Primary myelofibrosis of bone marrow

71.6

43.2

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

17.8

42.9

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

17.8

42.9

L01EK01

ATC

axitinib; oral

426.4

42.3

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.9

42.2

220

824

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

7.0

42.1

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

9.5

41.9

3004

Kela drug reimbursment

Osimertinib

115.0

41.9

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

10.9

41.8

ZX080

NOMESCO Finland

Image guided radiotherapy

4.7

41.4

221

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

10.7

41.2

L01EG02

ATC

everolimus; oral

146.4

40.9

L01XE08

ATC

[U] nilotinib

+∞

40.8

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

9.3

40.5

TQW20

NOMESCO Finland

Tatoe

7.9

40.1

N05BA06

ATC

lorazepam; systemic, sublingual

3.2

39.7

168

559

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

39.4

367

1808

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

10.0

39.3

FM1FN

NOMESCO Finland

Heart function isotope examination

11.3

39.0

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

4.4

38.4

100

239

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

7.3

37.8

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

6.7

37.5

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

4.5

37.0

216

A06AD11

ATC

lactulose; oral

2.2

36.9

388

2002

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.8

36.8

115

314

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

4.5

36.7

205

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

7.8

36.6

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

9.4

36.6

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

7.4

36.5

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

11.8

36.1

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

35.9

484

2737

R4190

NOMESCO Finland

Nutritional therapy

3.5

35.7

125

369

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

10.2

35.4

R4110

NOMESCO Finland

Physiotherapy

1.9

35.2

667

4224

SPAT1109

SPAT

Analgesia with portable analgesic pump

9.7

35.1

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

9.7

35.1

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

34.9

307

1471

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.9

34.9

169

607

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

6.3

34.9

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

3.1

34.2

155

536

328

Kela drug reimbursment

Nilotinib

342.8

34.0

1519, ,

Kela drug reimbursment

77.6

33.9

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.5

33.4

117

345

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

6.1

33.4

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

4.7

33.1

168

XG410

NOMESCO Finland

Flow-volume spirometry

3.3

33.0

130

413

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

5.5

33.0

119

3016

Kela drug reimbursment

Binimetinib and encorafenib

172.8

32.8

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

9.5

32.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.9

32.6

167

618

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

12.5

32.4

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

32.4

202

827

L03AA14

ATC

lipegfilgrastim; parenteral

4.7

32.4

163

L01AX03

ATC

temozolomide; systemic

8.7

32.3

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

7.4

32.3

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.6

32.3

204

841

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.8

32.1

156

WB501

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of primary tumour

62.8

32.1

R18

ICD-10 Finland

Ascites

4.4

32.1

193

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

3.9

32.0

250

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.6

31.9

173

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

10.5

31.6

324

Kela drug reimbursment

Dasatinib

+∞

31.3

3001

Kela drug reimbursment

Alectinib

+∞

31.3

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.7

31.2

102

287

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.4

31.1

189

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

10.2

31.0

1513

Kela drug reimbursment

Binimetinib and encorafenib

162.5

30.8

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

5.9

30.6

WF002

NOMESCO Finland

Radical radiotherapy

2.6

30.5

183

735

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.9

30.3

140

WW200, ,

SPAT

0.5

30.2

254

4834

C10AA07

ATC

rosuvastatin; oral

0.5

30.1

325

5666

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

5.4

30.0

111

L01EA03

ATC

nilotinib; oral

306.9

29.9

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

8.3

29.5

1504

Kela drug reimbursment

Alectinib

+∞

29.2

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

10.2

29.2

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.4

29.1

221

4380

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

4.9

28.9

134

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.1

28.3

126

431

L01EB04

ATC

osimertinib; oral

55.9

28.2

L01EB03

ATC

afatinib; oral

285.4

27.8

Z31.5

ICD-10 Finland

Genetic counselling

3.1

27.6

122

415

L01BC59

ATC

trifluridine, combinations; systemic

11.3

27.6

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

27.3

784

5506

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

8.9

27.2

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.6

27.2

173

714

WF003

NOMESCO Finland

Adjuvant radiotherapy

3.2

27.0

111

362

L01EC02

ATC

dabrafenib; oral

62.9

27.0

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.9

27.0

129

459

169

Kela drug reimbursment

Crizotinib

274.6

26.8

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

5.4

26.6

101

JDA63

NOMESCO Finland

Local excision of lesion of stomach

46.4

26.5

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

3.9

26.1

211

N03AX14

ATC

levetiracetam; systemic

3.4

26.0

288

TGA30

NOMESCO Finland

Thoracocentesis

6.7

24.7

L01EX03

ATC

pazopanib; oral

131.7

24.6

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

43.4

24.6

L01EX05

ATC

regorafenib; oral

43.4

24.6

D45

ICD-10 Finland

Polycythaemia vera

5.9

24.5

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

9.5

24.4

B03XA01

ATC

erythropoietin; parenteral

6.8

24.3

WX892

NOMESCO Finland

Monitored bed care

2.3

24.1

206

969

L01XE35

ATC

[U] osimertinib

+∞

24.0

L01XE36

ATC

[U] alectinib

+∞

24.0

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.3

23.8

294

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

7.3

23.8

L01XE16

ATC

[U] crizotinib

242.8

23.7

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

4.3

23.6

149

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

5.1

23.5

101

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.5

23.5

195

3788

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

23.4

290

1571

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

23.4

583

3908

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.3

23.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

6.2

23.3

Z2446

NOMESCO Finland

Social worker

2.5

23.3

156

659

Z3231

NOMESCO Finland

Registered nurse

1.7

23.2

586

3942

ZX070

NOMESCO Finland

Intensity modified radiotherapy

3.9

23.0

174

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

9.1

23.0

SPAT1255

SPAT

Intravenous administration of medicine

2.3

23.0

180

816

L01ED03

ATC

alectinib; oral

+∞

23.0

127

Kela drug reimbursment

Transplant complication

4.7

22.9

115

212

Kela drug reimbursment

Gout

4.0

22.8

171

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

4.5

22.7

128

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

4.8

22.7

108

N05CF01

ATC

zopiclone; oral

1.6

22.7

686

4828

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

8.2

22.7

H03AA01

ATC

levothyroxine sodium; systemic

1.7

22.5

497

3219

L01EE01

ATC

trametinib; oral

52.6

22.1

L01EX02

ATC

sorafenib; oral

52.6

22.1

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

8.2

21.8

L01EA02

ATC

dasatinib; oral

222.3

21.6

L02AE03

ATC

goserelin; implant

5.1

21.0

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.0

20.9

JFB00

NOMESCO Finland

Partial resection of small intestine

4.2

20.9

137

L01XE29

ATC

[U] lenvatinib

+∞

20.9

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

19.7

20.8

ZX100

NOMESCO Finland

Oral

4.6

20.8

108

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

8.8

20.7

1BA04, ,

NOMESCO Finland

212.1

20.6

C49.4

ICD-10 Finland

Malignant neoplasm: Connective and soft tissue of abdomen

111.2

20.6

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.7

20.5

114

440

C50

ICD-10 Finland

Malignant neoplasm of breast

3.4

20.5

228

B73

ICPC

Leukaemia

25.8

20.4

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.6

20.4

126

512

L01XX52

ATC

venetoclax; oral

22.6

20.4

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

3.5

20.4

204

5BA08, ,

NOMESCO Finland

7.5

20.4

L01BB05

ATC

fludarabine; systemic

32.9

20.2

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

20.1

1017

8004

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

21.0

19.9

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

3.8

19.8

165

L01XE15

ATC

[U] vemurafenib

+∞

19.8

372

Kela drug reimbursment

Idelalisib

+∞

19.8

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.5

19.7

190

3535

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

4.9

19.7

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.6

19.7

105

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

4.6

19.7

105

C64.80

ICD-10 Finland

Wilms tumour

29.2

19.6

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.9

19.6

319

D77

ICPC

Malignant digestive neopl other/NOS

7.8

19.6

399

Kela drug reimbursment

Venetoclax

21.8

19.5

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.6

19.4

102

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.4

19.4

143

631

R11

ICD-10 Finland

Nausea and vomiting

2.1

19.3

199

1006

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

4.1

19.2

128

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.8

19.2

155

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

19.1

770

5741

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

19.0

277

1580

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

5.3

18.9

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

18.9

136

593

OAB43, ,

SPAT

0.4

18.9

101

2355

ZXA00

NOMESCO Finland

Right side

1.6

18.8

573

4004

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

18.7

153

706

Z3226

NOMESCO Finland

Physiotherapist

1.7

18.7

387

2449

ZXE00

NOMESCO Finland

One hour or less

1.5

18.5

765

5725

H02AB09

ATC

hydrocortisone; systemic

3.4

18.5

207

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

4.1

18.5

123

C10AX09

ATC

ezetimibe; oral

0.4

18.4

134

2764

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

16.3

18.3

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

19.5

18.2

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.1

18.1

121

D70.89

ICD-10 Finland

Neutropenic splenomegaly

4.6

18.0

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

15.5

18.0

SPAT1088

SPAT

Blood transfusion

6.7

17.9

J01DB01

ATC

cefalexin; oral

1.7

17.8

1630

14466

WW200

NOMESCO Finland

Immunization

3.2

17.8

228

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

13.8

17.8

335

Kela drug reimbursment

Lapatinib

95.9

17.6

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

6.4

17.6

KAD00

NOMESCO Finland

Partial nephrectomy

6.8

17.4

SPAT1269

SPAT

Other puncture and/or drainage

6.8

17.4

A28

ICPC

Limited function/disability NOS

1.7

17.4

427

2821

N03AX16

ATC

[U] pregabalin

1.6

17.4

492

3367

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

21.1

17.3

3019

Kela drug reimbursment

Lenvatinib

42.4

17.3

KAC00

NOMESCO Finland

Nephrectomy

14.0

17.3

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.6

17.1

275

4405

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

5.1

17.0

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

16.9

307

1867

1514, ,

Kela drug reimbursment

25.8

16.9

3002

Kela drug reimbursment

Ribociclib

25.8

16.9

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.4

16.9

GD1AA, ,

SPAT

0.4

16.8

1828

N02AX02

ATC

tramadol; systemic, rectal

1.5

16.7

896

7038

NF3AA

NOMESCO Finland

Femur X-ray examination

3.1

16.7

221

EB4VA, ,

NOMESCO Finland

0.4

16.7

1947

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.3

16.6

196

L01EC03

ATC

encorafenib; oral

90.8

16.6

1XC14, ,

NOMESCO Finland

171.4

16.5

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

27.8

16.5

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

16.4

368

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

20.2

16.4

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

14.4

16.3

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

16.2

114

492

WPB10

NOMESCO Finland

Making a convalescent care decision

6.6

16.2

ZZF00

NOMESCO Finland

Graft of adipose tissue

5.5

16.2

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.5

16.1

1508

Kela drug reimbursment

Lenvatinib

47.9

16.0

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

4.3

16.0

L01EF02

ATC

ribociclib; oral

21.1

16.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

15.9

344

2193

B03BA03

ATC

hydroxocobalamin; parenteral

2.2

15.9

132

612

N02BE01

ATC

paracetamol; systemic, rectal

1.9

15.9

1809

16654

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

6.4

15.8

XX9XW, ,

NOMESCO Finland

6.4

15.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

15.8

149

728

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

5.9

15.7

E83.50

ICD-10 Finland

Hypercalcemia

3.8

15.7

125

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

15.7

808

6275

L01XE46

ATC

[U] encorafenib

+∞

15.6

L01XE41

ATC

[U] binimetinib

+∞

15.6

L01XX47

ATC

[U] idelalisib

+∞

15.6

L03AB04

ATC

interferon alfa-2a; parenteral

19.4

15.6

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

11.8

15.5

L01EE03

ATC

binimetinib; oral

161.2

15.5

325

Kela drug reimbursment

Erlotinib

161.2

15.5

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

12.4

15.4

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

12.4

15.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

6.7

15.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

11.3

15.3

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.9

15.2

114

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.7

15.2

300

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.8

15.2

283

1518, ,

Kela drug reimbursment

17.9

15.1

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

23.6

15.1

D07AA02

ATC

hydrocortisone; topical

1.8

15.1

251

1486

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.8

15.0

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

3.6

14.9

139

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

11.4

14.8

ZXA05

NOMESCO Finland

Left side

1.5

14.7

512

3656

9875/3-C42.1

ICD-O-3

Chronic myelogenous leukemia, BCR/ABL positive of bone marrow

+∞

14.6

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

4.1

14.5

100

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

14.5

828

6530

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

14.4

625

4671

AA1AD

NOMESCO Finland

CT of head and brain

1.5

14.3

640

4809

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.6

14.2

5BX04, ,

NOMESCO Finland

19.3

14.2

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

13.5

14.2

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

14.2

254

1535

SPAT1254

SPAT

Administration of medicine

1.7

14.1

297

1876

ZZR10

NOMESCO Finland

Flap of skin and muscle

4.8

14.0

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.4

13.9

406

N05AD01

ATC

haloperidol; systemic

2.8

13.8

252

8936/1-C16.9

ICD-O-3

Gastrointestinal stromal tumor, NOS, of stomach, NOS

53.7

13.8

1XC07, ,

NOMESCO Finland

11.5

13.8

R06AE07

ATC

cetirizine; oral

1.4

13.8

796

6274

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

5.7

13.7

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.0

13.6

199

OAA67, ,

SPAT

0.3

13.6

1333

170

Kela drug reimbursment

Bosutinib

+∞

13.6

363

Kela drug reimbursment

Crizotinib

140.9

13.5

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

12.9

13.4

GDG10

NOMESCO Finland

Bilateral transplantation of lung

25.9

13.4

Z94.2

ICD-10 Finland

Lung transplant status

21.3

13.3

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.4

13.3

370

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

3.8

13.3

107

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.0

13.2

203

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

5.0

13.1

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

12.2

13.1

OAB42, ,

SPAT

0.4

13.1

1725

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.3

13.0

152

1XC03, ,

NOMESCO Finland

10.1

13.0

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

19.2

12.9

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

19.2

12.9

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

19.2

12.9

EB1VA, ,

NOMESCO Finland

0.5

12.8

125

2351

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

4.8

12.6

1XC17, ,

NOMESCO Finland

+∞

12.5

ZX121

NOMESCO Finland

Central venous catheter

9.4

12.5

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

3.8

12.5

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

20.2

12.5

8936/1-C17.9

ICD-O-3

Gastrointestinal stromal tumor, NOS, of small intestine, NOS

130.8

12.4

8936/3-C17.9

ICD-O-3

Gastrointestinal stromal tumor of small intestine, NOS

130.8

12.4

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

3.0

12.3

189

TQW99

NOMESCO Finland

Other minor procedure on skin

2.1

12.3

126

635

TQB05

NOMESCO Finland

Puncture of skin of trunk

4.3

12.2

L01

ICPC

Neck symptom/complaint

0.5

12.2

110

2123

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

12.5

12.1

V03AE01

ATC

polystyrene sulfonate; oral

3.7

12.1

105

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

26.9

12.0

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.4

12.0

1285

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

5.3

12.0

C10AA05

ATC

atorvastatin; oral

0.7

11.9

606

7681

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.9

11.9

1XC02, ,

NOMESCO Finland

4.9

11.9

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

11.9

102

480

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.6

11.9

266

3980

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

11.8

138

729

N05BA04

ATC

oxazepam; oral

1.5

11.8

493

3630

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

11.7

329

2226

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

4.0

11.7

9960/3-C42.1

ICD-O-3

Myeloproliferative neoplasm, NOS, of bone marrow

16.5

11.7

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

4.8

11.7

WZC00, ,

SPAT

0.5

11.6

100

1964

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

11.5

191

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

11.5

164

TJA10

NOMESCO Finland

Laparocentesis

8.7

11.5

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.6

11.5

260

L01EB01

ATC

gefitinib; oral

+∞

11.5

L01XE14

ATC

[U] bosutinib

+∞

11.5

P20

ICPC

Memory disturbance

0.5

11.4

120

2209

PHE70

NOMESCO Finland

Thrombectomy of inferior vena cava

120.7

11.4

ZX108

NOMESCO Finland

Inhalation

4.7

11.4

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

5.4

11.4

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

11.9

11.3

N07BC02

ATC

methadone; systemic

8.4

11.3

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

11.2

406

2901

A05AA02

ATC

ursodeoxycholic acid; oral

3.6

11.2

101

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

5.6

11.2

C17.1

ICD-10 Finland

Malignant neoplasm: Jejunum

20.1

11.1

TGD00

NOMESCO Finland

Needle biopsy of lung

5.3

11.1

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

5.3

11.1

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

4.3

11.0

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

11.0

475

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

11.0

207

1266

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

11.0

177

1036

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

10.9

168

2767

R4110, ,

SPAT

0.5

10.9

108

2023

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

15.6

10.8

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.7

10.8

L04AA06

ATC

mycophenolic acid; systemic

3.1

10.8

149

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.0

10.8

C20

ICD-10 Finland

Malignant neoplasm of rectum

4.5

10.7

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.5

10.7

263

ZX114

NOMESCO Finland

Intramuscular

3.4

10.7

109

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.8

10.6

194

JAH00

NOMESCO Finland

Laparotomy

2.5

10.6

252

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

4.2

10.6

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

8.0

10.6

C43

ICD-10 Finland

Malignant melanoma of skin

9.2

10.5

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

14.3

10.5

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

14.3

10.5

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

0.7

10.5

316

4446

M25.5

ICD-10 Finland

Pain in joint

0.7

10.5

351

4835

M907, C6488,

ICD-10 Finland

110.6

10.4

L01ED01

ATC

crizotinib; oral

+∞

10.4

L15

ICPC

Knee symptom/complaint

0.6

10.4

261

3821

HAB40

NOMESCO Finland

Wedge excision of mammary gland

2.0

10.4

117

611

N06DX01

ATC

memantine; oral

0.3

10.4

926

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

12.1

10.3

NG1AA, ,

SPAT

0.3

10.3

816

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

8.2

10.3

J02AC03

ATC

voriconazole; systemic

10.6

10.3

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

10.2

331

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

23.5

10.2

BCA30

NOMESCO Finland

Unilateral adrenalectomy

23.5

10.2

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

7.5

10.2

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

3.7

10.2

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.8

10.1

188

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

5.3

10.1

L08

ICPC

Shoulder symptom/complaint

0.6

10.1

234

3489

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

11.3

10.1

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

10.1

10.0

L02AB02

ATC

medroxyprogesterone; systemic

4.6

10.0

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

10.0

129

706

L82

ICD-10 Finland

Seborrhoeic keratosis

0.6

9.9

189

2952

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

9.9

149

2472

Z2221

NOMESCO Finland

Medical doctor

1.4

9.9

494

3746

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

16.8

9.9

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.0

9.9

141

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

12.2

9.8

HAD40

NOMESCO Finland

Mastopexy

8.2

9.8

WX721

NOMESCO Finland

Oxygen concentrator therapy

8.2

9.8

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.9

9.8

158

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

9.8

504

3842

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

9.7

102

519

ZXD05

NOMESCO Finland

Urgent procedure

1.4

9.7

533

4110

C92.9

ICD-10 Finland

Myeloid leukaemia, unspecified

55.3

9.6

HA1RA, ,

SPAT

0.2

9.6

420

GDC00

NOMESCO Finland

Lobectomy of lung

5.3

9.6

J96.1

ICD-10 Finland

Chronic respiratory failure

2.7

9.6

199

C83.1

ICD-10 Finland

Mantle cell lymphoma

8.4

9.6

J01CA04

ATC

amoxicillin; systemic

1.4

9.5

1525

13888

S50

ICPC

Skin, Medication/prescr/renewal

4.6

9.5

Z51.88

ICD-10 Finland

Other specified medical care

2.6

9.5

200

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

10.1

9.5

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

15.1

9.5

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

7.2

9.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

9.5

320

2248

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

9.4

484

L01EX08

ATC

lenvatinib; oral

30.2

9.4

C16.29

ICD-10 Finland

Malignant tumor of the corpus ventriculi other or unspecified carcinoma

30.2

9.4

8000/3-C64.9

ICD-O-3

Neoplasm, malignant of kidney, NOS

30.2

9.4

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

17.6

9.4

1XC13, ,

NOMESCO Finland

17.6

9.4

SPAT1290

SPAT

Preparation of deceased person

12.4

9.4

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

4.4

9.3

WZC30, ,

SPAT

0.4

9.3

1162

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

8.7

9.3

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

8.7

9.3

J05AB11

ATC

valaciclovir; oral

1.5

9.2

280

1922

R83

ICPC

Respiratory infection other

0.6

9.2

169

2670

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

13.7

9.2

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

5.0

9.1

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

4.8

9.1

WF099

NOMESCO Finland

Other radiotherapy

4.6

9.1

D75.2

ICD-10 Finland

Essential thrombocytosis

4.6

9.1

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

11.5

9.1

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

4.0

9.1

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

15.6

9.0

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

9.0

213

1381

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

4.2

8.9

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.3

8.9

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

8.9

297

2081

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

6.8

8.8

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.9

8.8

134

JMA10

NOMESCO Finland

Transabdominal total splenectomy

4.7

8.8

1CD01, ,

NOMESCO Finland

9.5

8.8

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

9.5

8.8

M54.5

ICD-10 Finland

Low back pain

0.7

8.7

415

5400

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

14.1

8.7

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

14.1

8.7

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

50.2

8.7

M90.7

ICD-10 Finland

Fracture of bone in neoplastic disease

50.2

8.7

WD705, ,

NOMESCO Finland

50.2

8.7

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.5

8.7

204

ND2AA, ,

SPAT

0.2

8.7

429

S77

ICPC

Malignant neoplasm of skin

3.2

8.7

109

L01AA01

ATC

cyclophosphamide; systemic

6.6

8.7

M79.6

ICD-10 Finland

Pain in limb

0.7

8.6

570

7037

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

4.8

8.6

207

Kela drug reimbursment

Chronic arrhythmias

0.6

8.6

162

2541

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

16.4

8.5

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

8.5

446

F51.0

ICD-10 Finland

Nonorganic insomnia

0.6

8.5

109

1896

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.4

8.5

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

7.4

8.4

8936/3-C26.9

ICD-O-3

Gastrointestinal stromal tumor of gastrointestinal tract, NOS

90.4

8.4

A10BK03

ATC

empagliflozin; oral

0.5

8.4

1562

A98

ICPC

Health maint/preventive medicine

0.7

8.4

1757

18353

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.1

8.4

106

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

12.8

8.4

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

12.8

8.4

M05BA02

ATC

clodronic acid; systemic

4.7

8.4

WPA13

NOMESCO Finland

Palliative consultation

4.7

8.4

360

Kela drug reimbursment

Bosutinib

+∞

8.3

373

Kela drug reimbursment

Ponatinib

+∞

8.3

Z01.7

ICD-10 Finland

Laboratory examination

0.6

8.3

141

2275

A46

ICD-10 Finland

Erysipelas

1.5

8.3

297

2107

M01AH05

ATC

etoricoxib; oral

0.8

8.3

882

10200

3AA13, ,

NOMESCO Finland

10.8

8.3

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

8.3

166

1033

OAB44, ,

SPAT

0.4

8.3

1174

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

3.1

8.3

107

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

8.2

292

2069

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

14.5

8.2

Z51.0

ICD-10 Finland

Radiotherapy session

2.9

8.2

129

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

6.5

8.2

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.2

8.1

312

J01FF01

ATC

clindamycin; systemic

1.4

8.1

499

3902

OAB48, ,

SPAT

0.5

8.1

1244

ZX122

NOMESCO Finland

Intra-arterial

8.2

8.1

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.8

8.1

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

17.2

8.1

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

4.0

8.1

HAE99

NOMESCO Finland

Other reconstruction of breast

4.0

8.1

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.8

8.0

136

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.3

8.0

721

N06DA02

ATC

donepezil; oral

0.3

8.0

735

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

3.7

7.9

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

4.6

7.9

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

13.1

7.9

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

2.4

7.9

214

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

10.8

7.8

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

10.8

7.8

X19

ICPC

Breast lump/mass female

3.0

7.8

111

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

7.0

7.8

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

7.0

7.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

7.7

427

NAR00

NOMESCO Finland

Complete excision of tumour of bone or cartilage of spine, unspecified

45.2

7.7

XX4BW, ,

NOMESCO Finland

15.1

7.7

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

15.1

7.7

TPX15

NOMESCO Finland

Removal of vascular injection port

6.4

7.7

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

2.2

7.7

299

R96

ICPC

Asthma

0.5

7.7

1325

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.8

7.7

134

B01AF01

ATC

rivaroxaban; oral

0.6

7.6

118

1950

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.5

7.6

175

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

8.1

7.6

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

8.1

7.6

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

8.1

7.6

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

8.1

7.6

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

3.6

7.6

C34.02

ICD-10 Finland

Malignant tumor of the main bronchial adenocarcinoma

25.1

7.6

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

7.6

328

L03

ICPC

Low back symptom/complaint

0.7

7.6

316

4220

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

0.4

7.6

888

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

8.9

7.5

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.4

7.5

G47.3

ICD-10 Finland

Sleep apnoea

0.7

7.5

243

3402

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

7.5

133

801

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

4.3

7.5

ZZA00

NOMESCO Finland

Split skin graft

2.2

7.4

277

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

3.9

7.4

WC501

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of local recurrence of tumour

80.4

7.4

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

80.4

7.4

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.2

7.4

ZYC01, ,

SPAT

0.5

7.4

1205

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

3.3

7.4

A07AA02

ATC

nystatin; oral

1.8

7.4

114

661

TQW40, ,

SPAT

0.5

7.4

1397

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.1

7.3

305

E000001, ,

ATC

1.4

7.3

324

2391

JLC10

NOMESCO Finland

Distal pancreatectomy

8.4

7.3

8936/3-C17.1

ICD-O-3

Gastrointestinal stromal tumor of jejunum

+∞

7.3

L01EB02

ATC

erlotinib; oral

+∞

7.3

3017

Kela drug reimbursment

Brigatinib

+∞

7.3

WA010

NOMESCO Finland

Adjuvant whole body radiotherapy

+∞

7.3

WB502

NOMESCO Finland

Demanding pharmacotherapy for primary neoplasm, enzyme inhibitor or similar agent

+∞

7.3

3026

Kela drug reimbursment

Lorlatinib

+∞

7.3

JN4DD

NOMESCO Finland

Scout CT scan of torso

10.9

7.3

D72.9

ICD-10 Finland

Disorder of white blood cells, unspecified

6.8

7.3

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

6.8

7.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

9.4

7.3

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.5

7.3

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.0

7.2

105

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

7.2

287

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.3

7.2

223

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.0

7.2

C95.9

ICD-10 Finland

Leukaemia, unspecified

30.1

7.1

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

30.1

7.1

1XC08, ,

NOMESCO Finland

30.1

7.1

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.6

7.1

157

HA1AA, ,

SPAT

0.0

7.1

207

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

12.1

7.1

GDB10

NOMESCO Finland

Wedge resection of lung

12.1

7.1

G04BD12

ATC

mirabegron; oral

0.6

7.1

113

1852

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

10.1

7.0

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

2.3

7.0

232

SPAT1262

SPAT

Handing over of treatment supplies

1.4

7.0

330

2462

L04AX03

ATC

methotrexate; systemic

0.5

7.0

1167

D76

ICPC

Malignant neoplasm pancreas

6.3

6.9

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

6.3

6.9

G20

ICD-10 Finland

Parkinson disease

0.2

6.9

336

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.2

6.9

253

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2.3

6.9

234

M70.6

ICD-10 Finland

Trochanteric bursitis

0.6

6.9

117

1888

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

6.8

144

908

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.3

6.8

203

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.6

6.8

120

1920

YX9AW, ,

NOMESCO Finland

3.8

6.8

E66.01

ICD-10 Finland

Obesity due to excess calories

0.5

6.8

972

N06DA03

ATC

rivastigmine; oral, transdermal

0.3

6.8

526

L13

ICPC

Hip symptom/complaint

0.7

6.8

218

3061

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

11.0

6.8

8140/3-C34.2

ICD-O-3

Adenocarcinoma, NOS, of middle lobe, lung

40.2

6.8

8249/3-C25.9

ICD-O-3

Neuroendocrine tumor, grade 2 of pancreas, NOS

40.2

6.8

OAA65, ,

SPAT

0.5

6.8

1297

TPH00

NOMESCO Finland

Phlebotomy

4.3

6.8

L71

ICPC

Malignant neoplasm musculoskeletal

16.7

6.7

L04AD01

ATC

ciclosporin; systemic

2.6

6.7

138

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

3.9

6.7

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.6

6.7

148

2245

L01AA02

ATC

chlorambucil; oral

7.2

6.7

X21

ICPC

Breast sympt/compl female other

2.5

6.7

162

KAC01

NOMESCO Finland

Percutaneous endoscopic nephrectomy

22.6

6.7

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

6.7

370

2836

N17

ICPC

Vertigo/dizziness

0.6

6.7

114

1837

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.6

6.6

1453

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

6.6

423

9761/3-C42.0

ICD-O-3

Waldenstrom macroglobulinemia of blood

12.3

6.6

R06.0

ICD-10 Finland

Dyspnoea

1.3

6.6

530

4296

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

4.2

6.5

E86

ICD-10 Finland

Volume depletion

2.2

6.5

246

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

10.1

6.5

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.2

6.5

345

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

6.5

306

4020

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

6.5

254

1832

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

6.5

419

JN3AE, ,

SPAT

0.2

6.4

362

N03AX18

ATC

lacosamide; systemic

3.9

6.4

L17

ICPC

Foot/toe symptom/complaint

0.7

6.4

376

4775

8936/1-C17.1

ICD-O-3

Gastrointestinal stromal tumor, NOS, of jejunum

70.1

6.4

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

6.4

1031

11495

JAH01

NOMESCO Finland

Laparoscopy

1.9

6.4

399

JN1AE, ,

SPAT

0.2

6.4

280

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

6.4

516

DM1QA, ,

SPAT

0.2

6.4

283

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

6.6

6.3

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

8.2

6.3

GAC00

NOMESCO Finland

Biopsy of pleura

6.0

6.3

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

6.0

6.3

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

11.1

6.3

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

9.3

6.3

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

9.3

6.3

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

0.2

6.3

298

1529, ,

Kela drug reimbursment

+∞

6.3

L01ED05

ATC

lorlatinib; oral

+∞

6.3

L01EA04

ATC

bosutinib; oral

+∞

6.3

L01XE24

ATC

[U] ponatinib

+∞

6.3

T93

ICPC

Lipid disorder

0.5

6.2

1060

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.1

6.2

251

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

26.8

6.2

JFA73

NOMESCO Finland

Excision of lesion of small intestine

26.8

6.2

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

7.0

6.2

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.7

6.2

115

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

6.2

596

7078

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.2

6.2

232

D19

ICPC

Teeth/gum symptom/complaint

0.7

6.2

323

4176

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

3.1

6.2

RS221, ,

NOMESCO Finland

2.8

6.2

104

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.9

6.2

3AC01, ,

NOMESCO Finland

3.2

6.1

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

5.8

6.1

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

6.1

537

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

7.7

6.1

GAA31

NOMESCO Finland

Thoracoscopy

7.7

6.1

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.7

6.1

281

3709

SPAT1229

SPAT

Assessment of need for aid

1.6

6.1

144

934

ECB20

NOMESCO Finland

Oral alveoplasty

2.9

6.1

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

4.1

6.1

KKB10

NOMESCO Finland

Excision of retroperitoneal tumour

12.6

6.1

1AA09, ,

NOMESCO Finland

12.6

6.1

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

12.6

6.1

H02

ICPC

Hearing complaint

0.7

6.1

160

2338

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

6.7

6.0

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

10.0

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

901

2566

5.57

309.83

13.3

4.5

284.90

245.98

u/l

5.87

883

2430

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1035

3531

5.00

280.18

8.2

3.3

0.81

0.82

mmol/l

1.60

1017

3337

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1813

10407

8.86

239.40

35.1

6.8

10.15

11.87

umol/l

14.78

1799

9965

(4035726) Immunohistochemistry procedure

674

1833

5.04

236.44

1.6

1.4

—

(3023368) Bacteria identified in Blood by Culture

1270

5848

4.20

212.89

6.5

4.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1785

10896

6.89

196.49

41.6

9.8

3.62

4.16

e9/l

15.77

1762

9431

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

694

2336

4.02

177.28

9.2

4.2

27.25

20.33

ug/l

0.35

622

1919

(42870588) Differential panel, method unspecified - Blood

1274

6680

3.49

158.18

14.8

6.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1644

10244

4.38

153.64

17.7

7.6

1.21

mmol/l

0.23

1435

8876

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

81.12

146.31

14.9

2.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

232

366

7.04

143.22

2.6

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1524

9244

3.72

143.12

14.1

6.8

1.21

mmol/l

1.60

1499

8557

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

280

535

5.92

142.76

2.6

1.5

—

(3019069) Monocytes/Leukocytes in Blood

1484

8949

3.54

138.50

15.2

6.7

9.07

9.02

0.20

1462

8372

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

278

545

5.76

137.74

2.8

1.6

—

(3006504) Eosinophils/Leukocytes in Blood

1477

8938

3.49

135.79

15.1

6.6

2.68

2.82

1.46

1456

8360

(3002030) Lymphocytes/Leukocytes in Blood

1491

9096

3.50

134.76

15.1

6.6

26.21

27.01

1.54

1475

8609

(3022096) Basophils/Leukocytes in Blood

1474

8937

3.46

134.46

15.2

6.7

0.74

0.67

2.68

1454

8357

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

239

419

6.34

132.91

9.7

5.4

301.68

755.88

iu/ml

0.72

(3024561) Albumin [Mass/volume] in Serum or Plasma

1482

9072

3.44

131.78

12.2

5.3

33.07

35.26

g/l

37.36

1447

8528

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

809

3573

3.12

127.40

2.9

1.9

—

(3018418) pH of Serum or Plasma

1143

6212

2.96

121.91

11.2

4.3

7.40

0.39

1005

4504

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

147

176

8.93

114.73

1.9

1.5

—

(3018010) Neutrophils/Leukocytes in Blood

1426

8930

3.07

113.67

13.8

6.5

57.65

57.75

0.10

1407

8526

(3004809) Band form neutrophils/Leukocytes in Blood

200

349

6.26

111.29

8.3

3.9

1.93

1.40

1.20

191

317

(3006315) Basophils [#/volume] in Blood

1499

9726

3.15

110.55

13.4

6.4

0.04

e9/l

1.42

1392

8252

(3001604) Monocytes [#/volume] in Blood

1496

9699

3.15

110.42

13.5

6.4

0.61

0.60

e9/l

0.30

1394

8228

(3032080) INR in Blood by Coagulation assay

1470

9473

3.08

108.99

11.0

16.8

1.15

1.28

inr

30.63

1337

7918

(3015377) Calcium [Moles/volume] in Serum or Plasma

1210

7055

2.81

108.26

20.6

3.6

2.35

2.36

mmol/l

1.48

1179

6393

(3013115) Eosinophils [#/volume] in Blood

1521

10012

3.16

108.03

14.7

6.6

0.19

e9/l

0.13

1419

8645

(3019198) Lymphocytes [#/volume] in Blood

1504

9875

3.10

106.55

13.7

6.5

1.93

1.92

e9/l

0.05

1417

8601

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

220

454

5.32

102.11

1.7

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

652

2903

2.85

96.43

9.1

6.0

1.03

1.04

mmol/l

0.34

626

2702

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

286

771

4.16

95.09

3.3

2.6

—

(3035933) Granulocytes/Leukocytes in Blood

194

400

5.26

89.87

5.8

3.3

55.22

58.72

2.17

194

400

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

176

336

5.65

88.77

4.0

2.6

811.87

1730.63

u/ml

0.39

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

154

260

6.33

88.23

2.2

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1453

17694

0.35

88.06

4.8

6.4

2.62

mmol/l

0.03

1277

16337

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

600

2705

2.74

85.04

2.4

1.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

145

239

6.46

85.03

1.7

1.5

37.29

30.40

ng/l

0.46

145

239

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1401

17283

0.37

83.25

4.5

5.4

1.37

1.46

mmol/l

10.92

1242

15910

(3003434) Protein [Mass/volume] in Pleural fluid

164

311

5.65

83.23

1.4

1.5

36.11

32.24

g/l

3.47

157

281

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1425

17396

0.37

79.66

4.5

5.5

4.50

4.55

mmol/l

0.95

1262

16135

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1844

14556

4.38

79.40

40.9

8.7

90.65

80.68

u/l

10.46

1827

13833

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1359

16920

0.39

78.62

6.0

7.1

39.73

39.92

mmol/mol

0.35

1234

15734

(3023199) Leukocytes [#/volume] in Pleural fluid

150

278

5.75

77.94

1.5

1659.72

4930.99

e6/l

0.51

118

189

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

560

2533

2.68

77.93

2.5

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

458

4.61

77.10

2.0

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

653

3199

2.55

76.93

3.2

2.1

29.64

29.77

0.19

640

3108

(3028308) Erythrocytes [#/volume] in Pleural fluid

138

241

6.08

76.27

1.4

1.5

125142.78

112329.85

e6/l

0.07

130

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

128

208

6.51

76.01

3.1

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

132

222

6.30

75.78

3.0

1.5

—

(3017181) Myelocytes/Leukocytes in Blood

454

1870

2.85

75.53

9.5

4.4

1.42

0.85

3.91

323

593

(40768806) Pleura Pathology biopsy report

133

231

6.10

73.89

1.5

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1043

6395

2.32

72.94

4.4

2.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

174

395

4.73

71.64

2.0

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

155.74

71.48

19.6

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

141

268

5.58

71.23

2.0

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

878

5060

2.31

70.43

7.8

4.3

90.72

87.56

3.74

860

4961

(3013826) Glucose [Moles/volume] in Serum or Plasma

1561

11493

2.63

70.40

9.0

5.4

6.72

6.78

mmol/l

0.59

1537

11010

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1017

6238

2.28

70.17

9.3

3.2

42.15

33.42

u/l

2.57

983

5879

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

10.23

68.73

3.4

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

10.23

68.73

3.4

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

9.97

66.61

3.4

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

460

2023

2.65

66.52

10.0

7.6

9.25

10.30

mmol/l

2.61

448

1946

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

104

8.60

66.27

3.2

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

104

8.60

66.27

3.2

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

104

8.60

66.27

3.2

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

104

8.60

66.27

3.2

1.5

—

(3042936) Bacteria identified in Isolate by Culture

588

2914

2.44

65.96

2.3

2.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

277

932

3.29

65.15

2.2

1.9

6.71

2.16

ug/l

0.46

263

837

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

759

4221

2.29

65.08

10.4

3.1

2.48

2.46

mmol/l

5.69

730

3817

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

108

177

6.39

63.51

2.9

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

108

177

6.39

63.51

2.9

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

108

177

6.39

63.51

2.9

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

374

1517

2.80

63.10

1.9

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

422

1826

2.66

62.70

5.7

2.3

402.14

379.16

nmol/l

1.51

414

1690

(3042631) Mycobacterium sp identified in Specimen

137

287

5.05

61.95

2.3

2.6

—

(3012441) Differential panel - Pleural fluid

124

238

5.49

61.88

1.4

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

596

3059

2.35

61.04

2.7

2.8

20.84

22.58

2.41

583

2858

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

987

6220

2.16

60.81

5.1

2.7

62.52

73.98

u/l

0.41

962

5772

(3002179) Metamyelocytes/Leukocytes in Blood

410

1782

2.64

60.15

10.1

4.2

1.06

0.63

3.70

286

563

(3004789) Transferrin [Mass/volume] in Serum or Plasma

623

3286

2.30

59.63

2.8

2.7

2.21

2.29

g/l

2.42

601

3049

(3045142) Bone marrow Pathology biopsy report

128

262

5.15

59.42

1.7

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1359

16575

0.44

59.22

4.1

4.6

1.45

1.29

mmol/l

4.88

1190

15098

(3027945) Reticulocytes/Erythrocytes in Blood

528

2601

2.40

59.13

5.4

2.7

1.94

1.83

1.68

493

2318

(40758558) Short blood count panel - Blood

934

5849

2.12

57.51

31.3

6.5

—

(3021440) Promyelocytes/Leukocytes in Blood

405

1787

2.59

57.37

9.9

4.5

0.18

0.10

1.93

275

512

(3022948) Iron [Moles/volume] in Serum or Plasma

644

3499

2.24

56.94

2.9

2.8

11.58

12.73

umol/l

3.94

626

3272

(3042111) Morphology [Interpretation] in Bone marrow Narrative

158

399

4.21

56.57

2.3

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

9.59

56.49

1.7

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

426

7879

0.42

56.11

2.0

1.63

1.33

mmol/l

3.61

349

6535

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

470

2254

2.42

55.48

5.5

2.8

11.50

8.61

umol/l

1.34

446

2027

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

128

280

4.82

54.93

1.1

—

(21494434) Karyotype in Bone marrow

113

226

5.24

53.81

1.5

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

438

2080

2.42

52.55

2.7

2.2

0.20

0.21

g/l

1.65

410

1951

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

136

324

4.43

52.48

1.3

1.4

150.89

162.56

au/ml

0.42

106

(3009214) Lutropin [Units/volume] in Serum or Plasma

141

346

4.31

52.37

1.6

1.3

14.80

10.18

u/l

2.16

119

274

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

145

365

4.20

52.08

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

179

534

3.58

50.50

1.3

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

120

268

4.70

50.18

2.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

120

268

4.70

50.18

2.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

120

268

4.70

50.18

2.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

120

268

4.70

50.18

2.6

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

144

372

4.09

49.92

1.3

—

18.97

—

(3023520) Reticulocytes [#/volume] in Blood

426

2057

2.36

48.87

5.9

2.7

72.44

69.68

e9/l

0.79

319

1513

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

131

328

4.20

47.34

1.9

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

401

1918

2.36

46.82

3.8

3.0

64.06

66.44

g/l

7.01

385

1778

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

223

802

3.00

46.22

3.3

1.9

—

(3026782) Osmolality of Urine

660

3883

2.04

45.53

3.6

3.1

523.60

529.99

mosm/kgh2o

0.34

617

3409

(3045788) Cell count panel - Pleural fluid

106

233

4.75

45.16

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

142

393

3.81

44.66

1.9

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

873

5690

1.95

44.65

4.1

3.4

0.57

0.45

e6/l

0.50

736

4219

(3024471) HLA-A [Type]

10.44

44.09

1.0

—

(3037121) Protein [Mass/volume] in Urine

203

715

3.05

43.57

4.3

3.3

306.88

381.12

mg/l

0.37

164

311

(3002582) Erythrocytes [#/volume] in Urine

970

6586

1.92

43.52

4.2

3.6

55.37

82.97

e6/l

0.89

823

5080

(3017354) Segmented neutrophils/Leukocytes in Blood

103

231

4.65

42.81

10.7

3.7

55.15

57.49

0.41

203

(3008757) Leukocyte morphology finding [Identifier] in Blood

100

220

4.73

42.55

13.7

4.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1537

12250

2.10

42.09

5.5

5.0

902.67

1644.46

e6/l

0.45

180

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1216

8994

1.90

40.84

4.9

2.9

—

estimate

—

(3024932) HLA-DR beta [Type]

9.99

40.16

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

201

740

2.91

39.77

2.3

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

259

1087

2.59

39.76

1.6

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

768

4946

1.90

39.43

4.2

2.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

197

724

2.91

39.09

3.8

3.0

0.38

0.35

iu/ml

0.53

116

403

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

214

825

2.78

38.83

3.4

3.6

71.13

1968.61

u/ml

0.95

185

718

(3025159) Blasts/Leukocytes in Blood

366

1817

2.24

38.50

10.2

4.6

0.60

0.11

1.04

236

490

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

167

565

3.13

38.31

1.8

1.7

—

(3035880) pH of Pleural fluid

122

5.82

37.50

1.3

1.4

7.42

7.40

0.29

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

7.37

36.96

2.6

1.9

34141.77

4101.00

u/ml

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

273

1215

2.44

36.87

4.1

3.7

1.55

1.97

mmol/l

0.91

203

913

(3021589) Normoblasts [#/volume] in Blood

1131

8335

1.82

36.69

28.1

12.3

0.04

0.00

e9/l

3.02

1007

6789

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

157

532

3.12

35.89

2.3

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

108

288

3.91

35.74

6.2

2.3

298.66

60.24

u/ml

1.12

108

281

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

177

4.79

35.68

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

132

406

3.41

35.35

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

132

406

3.41

35.35

1.6

1.3

—

(40768804) Tissue Pathology biopsy report

1051

7641

1.79

35.04

2.7

2.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

178

660

2.86

34.65

1.6

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

259

1159

2.42

34.45

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

314

1532

2.24

34.16

4.3

2.9

9.14

10.78

g/l

7.93

296

1411

(3008536) Aspergillus sp Ab [Presence] in Serum

9.28

33.95

3.3

1.5

—

(3009343) pH of Capillary blood

293

1395

2.29

33.78

4.4

3.9

7.42

0.18

252

1173

(3011412) CD3 cells [#/volume] in Blood

174

4.69

33.55

4.5

1.9

2244.43

1135.88

e6/l

0.45

154

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1519

17224

0.51

33.20

5.3

5.7

6.10

6.03

mmol/l

1.03

1344

15719

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

327

1644

2.18

32.96

9.3

3.9

1.22

1.23

mmol/l

0.36

316

1429

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

295

1429

2.25

32.57

4.4

3.9

5.09

5.16

kpa

0.77

278

1377

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

6.08

32.55

4.2

3.8

1.66

1.19

0.93

(3036489) Thrombin time

185

726

2.71

32.29

3.6

2.0

21.62

21.21

0.50

178

659

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

161

4.73

31.90

1.8

1.6

—

(40768441) Liver Pathology biopsy report

146

4.93

31.72

1.3

1.4

—

(3003396) Base excess in Arterial blood by calculation

445

2541

1.97

31.66

7.3

7.7

1.16

0.92

mmol/l

0.61

352

2100

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

160

4.70

31.19

1.4

11.55

13.41

u/l

1.53

152

(40760892) CBC W Ordered Manual Differential panel - Blood

628

4026

1.82

31.08

11.0

4.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

173

4.53

31.00

2.4

15.14

37.32

iu/ml

1.21

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

11.60

30.96

2.2

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

284

1385

2.22

30.75

1.8

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

540

3314

1.86

30.73

3.7

3.2

2.37

2.20

e6/l

0.17

336

1655

(3019977) pH of Arterial blood

443

2553

1.94

30.55

7.4

7.8

7.43

7.41

2.79

277

1396

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

371

2013

2.03

30.39

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

443

2558

1.94

30.35

7.4

7.8

4.95

5.10

kpa

2.93

424

2466

(3017143) Hepatitis C virus Ab [Presence] in Serum

336

1759

2.09

30.32

1.5

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

233

1053

2.37

30.16

2.0

1.8

1.59

1.53

g/l

0.28

206

916

(3027801) Oxygen [Partial pressure] in Arterial blood

442

2559

1.93

30.01

7.4

7.8

12.13

12.23

kpa

0.13

421

2466

(3018095) Leukocytes [#/volume] in Urine

994

7348

1.70

29.19

4.9

4.2

75.94

111.60

e6/l

0.93

829

5284

(3012501) Base excess in Blood by calculation

122

402

3.17

29.18

6.5

4.9

2.83

2.53

mmol/l

0.55

278

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

112

5.21

27.66

5.5

2.0

1224.27

536.13

e6/l

0.55

(3028433) Virus identified in Specimen by Culture

6.84

27.65

1.6

1.1

—

(1761868) Lipid panel - Serum or Plasma

382

6177

0.53

27.21

2.9

3.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

166

4.33

27.12

1.6

1.3

35.50

33.29

u/l

0.19

133

(3000850) Epithelial cells [#/volume] in Urine

679

4603

1.72

26.88

3.2

2.8

5.51

5.40

e6/l

0.05

640

4213

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

139

4.65

26.71

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

7.21

26.32

2.2

1.4

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

5.92

26.23

1.3

1.6

71.53

59.58

1.24

(1616796) Gas panel - Central venous blood

126

451

2.91

26.08

4.9

4.1

—

(3023419) Bacteria identified in Sputum by Culture

308

3.33

26.01

2.6

2.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

121

4.82

25.32

1.8

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

341

1914

1.94

24.96

3.0

2.5

71.35

40.23

u/l

0.39

310

1613

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

117

4.81

24.37

2.4

2.7

36.43

40.05

0.59

(3014111) Lactate [Moles/volume] in Serum or Plasma

348

1987

1.91

24.13

8.0

7.7

1.47

1.34

mmol/l

1.38

342

1953

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

126

4.63

24.12

1.8

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

101

335

3.12

23.89

1.2

308.51

260.76

u/ml

0.79

189

(3023183) Ammonium ion [Moles/volume] in Plasma

124

472

2.73

22.88

2.2

2.8

40.63

33.12

umol/l

2.47

117

424

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

170

755

2.37

22.73

4.7

4.0

24.72

24.91

mmol/l

0.38

157

705

(3001893) Eosinophils/Leukocytes in Pleural fluid

5.81

21.99

1.2

1.6

2.87

2.99

0.02

(3028026) IgM [Mass/volume] in Serum or Plasma

237

1221

2.07

21.95

3.5

1.9

1.82

1.45

g/l

0.70

211

1126

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

25.35

21.76

1.3

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

121

468

2.69

21.64

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

142

4.18

21.59

1.8

1.4

—

(40765096) Chromosome analysis panel by Banding

5.41

21.40

1.2

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

252

1346

2.00

21.09

9.0

9.7

24.38

24.27

mmol/l

0.20

245

1326

(3052851) Hemolysis interference index of Serum or Plasma

132

542

2.54

20.92

3.8

3.6

4.10

2.03

index

1.62

283

(3019225) pH of Specimen

338

1999

1.83

20.75

11.1

4.5

7.38

7.35

2.61

317

1431

(3022313) Gas panel - Capillary blood

198

991

2.11

19.74

4.7

3.9

—

(1175426) CD3 cells/Lymphocytes in Blood

139

4.04

19.64

3.2

1.8

65.15

73.23

1.63

127

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

531

3613

1.64

19.54

3.6

3.1

1.16

1.11

e6/l

0.10

331

1965

(3016502) Oxygen saturation in Arterial blood

371

2294

1.76

19.51

8.1

8.0

94.98

95.60

0.96

353

2219

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

106

4.52

19.44

1.6

1.1

—

(3002032) Base excess in Venous blood by calculation

351

2138

1.78

19.43

5.5

3.7

1.82

1.87

mmol/l

0.08

286

1864

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

122

500

2.53

19.41

3.3

596.21

851.06

u/ml

0.17

110

465

(3012516) Albumin [Mass/volume] in Urine

498

7025

0.61

19.30

3.5

3.6

113.76

46.11

mg/l

4.20

354

4523

(3012544) pH of Venous blood

361

2221

1.76

19.30

5.4

3.8

7.38

0.13

238

1272

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

194

3.48

18.98

3.0

2.7

—

(3034426) Prothrombin time (PT)

6.41

18.84

1.0

1.4

28.74

28.69

0.01

(3026008) Bacteria identified in Urine by Culture

806

6123

1.53

18.11

3.3

3.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

713

5283

1.54

17.92

2.3

2.4

3.50

2.85

mg/l

5.03

647

4552

(3021447) Carbon dioxide [Partial pressure] in Venous blood

351

2196

1.73

17.55

5.5

3.7

5.72

5.83

kpa

1.00

344

2141

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

175

3.50

17.48

1.1

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

204

1084

1.98

17.22

4.1

3.5

4.25

4.42

pmol/l

1.47

187

960

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

104

4.30

17.17

8.1

6.7

458.37

205.40

ug/l

0.26

(3009508) Creatinine [Moles/volume] in Urine

528

7186

0.64

16.68

3.4

3.5

6.98

7.34

mmol/l

1.28

429

6045

(3026493) Urate [Moles/volume] in Serum or Plasma

694

5180

1.52

16.55

7.4

3.0

356.38

348.64

umol/l

1.01

630

4532

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

559

3983

1.56

16.48

4.8

4.1

487.98

402.50

ng/l

0.26

468

3300

(3020682) Albumin/Creatinine [Ratio] in Urine

527

7148

0.64

16.25

4.1

4.3

19.26

8.26

mg/mmol

3.63

353

4479

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

225

3.09

16.20

3.5

3.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

846

6600

1.49

16.18

3.3

1560.79

1310.14

ng/l

0.92

778

5750

(3042733) HLA Ab [Presence] in Serum

5.90

15.73

3.5

4.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

119

532

2.32

15.65

1.6

1.4

27.04

32.23

iu/l

0.87

457

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1371

0.30

15.38

1.4

2.1

3.28

3.47

ratio

0.61

1106

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

256

2.88

15.14

2.1

1.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

20.20

15.10

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

11.88

15.06

1.1

1.0

—

(40768793) Breast Pathology biopsy report

108

471

2.37

15.04

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

257

2.87

15.03

2.1

1.4

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

4.85

14.97

1.3

1.5

8.89

28.58

4.50

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

259

2.85

14.83

2.1

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

400

2.47

14.78

1.4

1.3

89.33

40.64

u/l

1.09

350

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

131

3.65

14.68

3.4

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

349

2281

1.64

14.58

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

945

7635

1.45

14.58

4.5

4.1

30.30

75.44

ng/l

2.46

829

5770

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

252

3987

0.58

14.55

1.2

1.3

0.98

1.46

u/ml

1.37

1047

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.98

14.53

1.2

1.3

715.05

61.82

ug/l

1.34

(3000991) Gas panel - Venous blood

304

1922

1.69

14.43

10.7

8.9

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

248

2.85

14.24

2.1

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

248

2.85

14.24

2.1

1.4

—

(3000012) Reticulocyte production index

329

2.59

14.18

5.4

2.2

0.97

0.89

0.56

232

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

810

6386

1.45

14.08

3.6

2.2

167.80

217.72

u/l

1.33

776

6052

(3005988) Vibrio sp identified in Specimen by Organism specific culture

250

2.82

14.03

2.1

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

276

1715

1.71

13.95

3.1

168.47

199.18

ng/l

0.95

253

1581

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

148

756

2.03

13.92

1.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

168

898

1.95

13.90

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

108

3.85

13.89

1.6

6.18

6.42

u/l

0.03

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

118

3.70

13.75

2.9

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

118

3.70

13.75

2.9

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

312

2.59

13.61

1.2

1.0

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

982

0.23

13.60

1.2

1.9

3.42

3.48

mmol/l

0.10

719

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.15

13.49

2.3

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.15

13.49

2.3

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

159

3.27

13.45

7.9

5.2

213.49

38.77

u/ml

0.86

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

125

3.58

13.39

2.2

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

123

599

2.12

13.15

7.5

3.2

1.52

1.66

mg/l

1.33

117

538

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

558

4136

1.48

13.15

2.3

1.8

2.27

1.37

mg/l

3.01

486

3241

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1854

17371

1.91

13.02

51.4

18.1

27.93

25.81

mg/l

2.08

1813

14523

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

5.26

12.97

1.1

1.2

78.89

86.15

0.49

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.17

12.94

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

5.15

12.69

1.1

1.6

79.58

86.68

0.36

(3002173) Hemoglobin [Mass/volume] in Arterial blood

323

2147

1.60

12.46

9.1

8.5

118.46

120.84

g/l

1.12

314

2097

(3000494) Fungus identified in Specimen by Culture

350

2373

1.58

12.41

2.3

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

4.96

12.16

1.1

1.3

91.00

105.90

0.87

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

124

3.44

12.08

2.2

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

401

5502

0.66

12.07

3.4

4.9

21.00

21.48

0.25

194

2898

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

105

3.67

12.06

1.5

2.1

100.53

101.97

0.08

100

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

313

2093

1.59

11.73

4.8

3.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.05

11.47

1.1

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.90

11.11

2.1

1156.32

812.43

e6/l

0.33

(3006184) Hemoglobin [Mass/volume] in Capillary blood

104

508

2.10

11.06

2.5

2.3

123.26

129.09

g/l

1.22

411

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

104

508

2.10

11.06

1.5

2.1

11.05

12.19

mg/l

0.56

473

(4195642) Thrombophilia screening test

224

2.68

11.04

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

11.21

11.04

1.2

1.6

22.20

16.73

0.20

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

102

3.58

11.04

3.6

3.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

390

2.26

11.00

1.2

1.3

108.00

348.89

titre

—

(3044007) Cell count panel - Peritoneal fluid

4.40

10.99

2.2

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

280

4066

0.64

10.83

2.7

3.5

0.89

0.77

ug/l

0.94

203

2835

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

15.57

10.82

1.1

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.07

10.69

2.0

1.9

11248.86

25423.52

e6/l

0.26

(21494755) Public health laboratory ask at order entry panel

1013

0.32

10.63

1.0

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

253

2.54

10.55

1.2

1.64

4.16

u/ml

1.25

(40761536) Microorganisms panel - Urine sediment

231

1472

1.64

10.51

4.6

4.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

310

2.37

10.39

8.1

6.5

11.15

12.24

mg/l

1.46

294

(4268621) Lupus anticoagulant assay

177

2.81

10.10

2.2

2.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

109

3.34

10.00

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

242

2.53

9.98

5.5

3.5

14.23

27.29

nmol/l

0.24

237

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

246

2.48

9.65

1.1

1.2

2.69

5.65

u/ml

1.42

111

(3008152) Bicarbonate [Moles/volume] in Arterial blood

211

1343

1.64

9.63

5.5

6.6

24.67

24.47

mmol/l

0.34

199

1283

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

111

585

1.95

9.60

1.9

1.3

—

(3003181) Sodium [Moles/volume] in Urine

434

2.10

9.54

1.4

58.20

59.35

mmol/l

0.10

346

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

184

2.70

9.41

1.1

1.2

102.33

95.34

1.01

174

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

156

2.86

9.40

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

201

1272

1.64

9.38

11.4

10.2

15.57

15.94

0.98

192

1227

(40758292) HTLV I+II Ab panel - Serum

5.04

9.09

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

167

2.73

8.86

1.1

1.0

—

(40757373) Influenza virus identified in Isolate

4.69

8.82

1.9

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

239

2.43

8.77

1.1

—

(3047181) Lactate [Moles/volume] in Blood

112

611

1.88

8.76

5.3

5.9

1.31

1.32

mmol/l

0.04

540

(3024354) Oxygen [Partial pressure] in Venous blood

266

1827

1.53

8.74

5.2

3.1

4.55

4.53

kpa

0.07

259

1779

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

355

2.16

8.70

1.1

1.2

220.11

224.31

miu/ml

0.02

139

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

6.62

8.65

1.2

1.9

2.64

8.47

1.34

(40760409) HLA-A [Type] by High resolution

16.35

8.55

1.0

—

(46236302) HLA-C [Type] by High resolution typing

16.35

8.55

1.0

—

(40760410) HLA-B [Type] by High resolution

16.35

8.55

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

317

2284

1.46

8.21

1.5

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

130

2.88

8.08

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

164

2.66

8.06

1.5

1.4

0.20

0.29

nmol/l

0.87

120

(40768795) Lymph node Pathology biopsy report

200

2.49

8.01

1.2

—

(3002256) Pathology report gross observation

362

2686

1.42

8.00

1.5

1.3

—

(40763590) HLA-DQ beta [Type]

15.08

7.71

1.0

—

(3013862) HLA-DP [Type]

15.08

7.71

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

125

2.83

7.44

1.7

2.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

477

1.91

7.39

1.5

2.0

2.84

15.66

iu/l

0.55

196

(3014148) Varicella zoster virus Ab [Titer] in Serum

178

2.50

7.35

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

481

1.89

7.21

1.5

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

7.32

7.18

7.7

2.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

4.50

7.18

1.6

1.1

—

(4015189) Microbial culture of sputum

3.78

7.08

2.2

2.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

297

2.12

7.04

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

330

2469

1.40

6.89

5.3

3.3

6.55

4.56

e9/l

0.69

301

2113

(3026250) Tacrolimus [Mass/volume] in Blood

3.36

6.83

45.6

36.4

8.46

7.01

ug/l

2.52

(3019309) Folate [Moles/volume] in Red Blood Cells

447

3524

1.35

6.73

1.8

1175.11

1178.53

nmol/l

0.02

361

2667

(3007566) Smooth muscle Ab [Titer] in Serum

537

1.81

6.70

1.1

1.2

148.57

96.82

titre

—

(3020393) Adenovirus Ag [Presence] in Stool

10.05

6.53

2.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

214

2.27

6.51

1.1

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

338

2565

1.38

6.47

1.3

476.46

505.61

titre

0.10

595

(3014891) Appearance of Pleural fluid

5.71

6.45

1.9

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

413

1.90

6.42

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

6.56

6.33

1.7

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

6.56

6.33

1.7

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

6.56

6.33

1.7

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

573

6847

0.77

6.27

4.1

6.0

2.48

2.95

ug/l

0.99

502

6166

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

18.07

6.26

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

643

0.37

6.11

2.1

1.8

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

6.70

6.03

1.9

2.2

0.99

1.23

mg/l

—

(1002224) Polysomnography panel

709

0.40

6.01

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.89

5.99

1.1

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

346

1.94

5.91

1.2

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

130

831

1.60

5.88

1.5

1.9

44.03

38.90

u/l

1.79

113

732

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

285

2.03

5.84

1.1

1.60

1.53

g/l

0.78

262

(3013139) Helicobacter pylori Ag [Presence] in Stool

1275

0.56

5.60

1.2

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

105

2.69

5.50

1.1

145.93

81.48

u/l

1.84

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

791

0.46

5.49

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

762

8706

0.80

5.48

2.7

2.5

75.53

78.79

nmol/l

2.50

702

7795

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.88

5.43

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

106

2.66

5.41

1.1

69.04

25.62

u/l

1.74

(3008898) HLA-B27 [Presence]

514

0.34

5.29

1.0

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

5.41

5.22

1.2

1.3

64.71

72.60

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.35

5.16

1.2

1.0

—

(3003694) ABO and Rh group [Type] in Blood

590

5003

1.25

4.89

1.5

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.24

4.82

1.3

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

11.47

4.78

2.3

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.42

4.75

1.7

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

164

2.22

4.73

1.3

1.2

117.97

103.39

pmol/l

0.69

164

(36660697) Celiac disease serology panel - Serum

1414

0.63

4.59

1.1

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

403

0.32

4.55

1.2

1.62

1.55

g/l

0.29

403

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.84

4.49

1.2

1.3

51.40

80.67

—

(3014007) Fractional oxyhemoglobin in Arterial blood

200

1483

1.39

4.39

11.5

9.7

92.85

94.03

1.16

200

1476

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

251

3215

0.75

4.37

1.2

1.3

10.25

12.95

u/ml

0.24

1183

(3000570) Elastase.pancreatic [Mass/mass] in Stool

634

1.57

4.29

1.4

1.5

234.92

275.73

ug/g

1.13

390

(3020961) Endomysium IgA Ab [Titer] in Serum

780

0.53

4.17

1.1

—

129.50

titre

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

691

0.51

3.98

1.1

1.6

0.10

0.33

mg/l

—

315

(3016038) Potassium [Moles/volume] in Urine

150

2.15

3.97

1.3

1.1

36.11

34.88

mmol/l

0.10

134

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.14

3.93

1.3

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

400

0.37

3.90

1.7

1.9

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

12.03

3.76

2.7

1.6

—

(3039000) Anion gap in Blood by calculation

424

1.65

3.76

6.3

6.8

11.00

11.26

mmol/l

0.30

378

(3018572) Chloride [Moles/volume] in Blood

424

1.65

3.76

6.3

6.8

104.44

105.20

mmol/l

0.87

378

(3015956) Eosinophils/Leukocytes in Blood by Manual count

3.84

3.69

3.2

2.0

2.04

2.46

0.23

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1570

16378

0.81

3.65

8.9

5.6

2.32

1.98

mu/l

5.45

1477

15021

(3000060) B lymphocytes [#/volume] in Blood

3.52

3.60

7.1

2.0

0.12

0.22

e9/l

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

195

1492

1.34

3.54

11.4

9.5

1.22

1.25

0.19

195

1481

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

803

0.58

3.54

1.4

1.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

158

1171

1.38

3.52

4.1

2.8

1.18

1.16

0.14

158

1163

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.34

3.50

1.7

2.7

1510.87

1348.46

u/ml

0.14

(40768446) Kidney Pathology biopsy report

2.62

3.47

1.1

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

135

977

1.41

3.46

5.0

4.9

1.60

1.56

0.28

128

921

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

334

0.36

3.45

1.7

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.59

3.38

3.4

2.5

0.59

0.61

mmol/l

0.56

(40765089) Chromosome analysis panel - Blood by G-banded

5.02

3.37

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.84

3.36

1.2

1.9

11.53

2.92

ug/l

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1321

13975

0.84

3.35

65.0

23.9

328.95

331.74

g/l

19.04

1311

13910

(3020891) Body temperature

139

1017

1.39

3.35

4.7

4.3

36.95

36.91

°c

0.69

139

1008

(3000475) Leukocytes [#/volume] in Synovial fluid

559

0.51

3.30

1.4

1.6

11039.74

14767.34

e6/l

0.50

388

(3017569) Oxygen content in Arterial blood

128

2.12

3.30

3.0

2.5

17.54

16.04

1.14

128

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.93

3.30

6.2

2.5

6.00

4.60

ug/l

0.35

(3019550) Sodium [Moles/volume] in Serum or Plasma

1858

18102

1.37

3.26

49.5

21.9

138.80

139.69

mmol/l

39.47

1839

17778

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

8.59

3.26

2.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

3.04

3.25

2.5

1.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

288

1.72

3.19

1.2

1.1

—

12.15

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.35

3.19

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

291

0.34

3.18

1.8

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

222

1.82

3.16

1.3

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

213

1683

1.30

3.10

3.6

3.9

106.86

91.68

ng/l

1.21

189

1460

(4094501) Cardiovascular stress test using bicycle ergometer

557

0.53

3.06

1.1

—

(3022475) Manganese [Moles/volume] in Blood

7.52

3.05

1.3

1.4

0.22

0.15

umol/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.02

3.05

1.0

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

490

1.53

3.01

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1858

18130

1.35

2.97

50.6

22.1

4.02

3.99

mmol/l

4.61

1837

17783

(3014765) Yersinia sp identified in Stool by Organism specific culture

500

1.52

2.96

1.1

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.25

2.96

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

205

1.82

2.95

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

169

2161

0.76

2.90

2.3

2.4

249.85

144.50

ug/g

1.42

141

1728

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

495

1.51

2.89

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

505

1.50

2.84

1.1

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

223

1795

1.27

2.82

2.2

2.5

9.00

7.48

ug/l

0.40

197

1612

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.35

2.81

1.5

1.3

2661.00

1121.50

u/l

0.26

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

204

1628

1.28

2.77

7.4

2.8

52.65

62.68

ml/min/173m2

4.37

720

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

151

1159

1.33

2.73

4.2

2.8

0.62

0.61

0.34

151

1153

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.72

1.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

903

0.65

2.71

1.1

—

2.00

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

890

0.65

2.70

1.4

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

120

892

1.37

2.68

5.3

5.2

0.86

0.00

112

840

(3019832) Treponema pallidum Ab [Presence] in Serum

106

773

1.39

2.66

1.3

1.6

—

(3016750) Collection duration of Urine

119

2.03

2.66

1.7

2.2

475.71

488.64

min

0.26

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

201

0.35

2.66

1.0

1.1

—

2.19

—

(3038026) Centromere Ab [Units/volume] in Serum

164

1.84

2.53

1.2

1.1

—

51.98

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

122

1.98

2.50

3.8

1.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

211

1.72

2.43

1.3

1.1

—

61.00

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

903

8354

1.15

2.42

3.5

3.1

313.71

140.11

ug/l

12.89

853

7745

(3030313) Adrenal Ab [Titer] in Serum

6.26

2.37

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

453

1.47

2.33

1.2

1.19

4.69

u/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

237

1.66

2.33

5.0

6.1

6.95

7.37

mmol/l

0.50

201

(4024509) Urine culture

964

0.70

2.30

2.4

2.0

—

(3012565) Volume of 24 hour Urine

2.08

2.27

2.0

2.8

1803.16

1871.44

0.10

(3045414) Leukocytes [Presence] in Urine

156

1949

0.78

2.26

2.4

2.2

0.00

0.01

estimate

0.78

386

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

358

1.52

2.26

1.4

1.5

116.61

255.59

pmol/l

1.87

352

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

839

9042

0.88

2.25

2.1

2.2

88.57

95.13

pmol/l

3.73

528

4775

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

311

1.56

2.23

1.1

1.2

—

1.10

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.69

2.15

4.1

5.5

—

(3004775) Volume in Urine collected for unspecified duration

160

1.76

2.10

1.9

2.3

637.56

623.79

0.07

103

(4062490) Immunoglobulin typing, IgG

175

1.73

2.10

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.27

2.07

3.1

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.01

2.07

7.4

4.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

269

1.57

2.07

2.2

2.3

1.36

1.24

g/24h

0.11

155

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

359

1.49

2.03

1.1

1.4

—

9.63

—

(3036048) Francisella tularensis Ab [Titer] in Serum

2.51

2.01

1.2

1.1

—

(4212803) Bone marrow aspirate examination

3.34

1.96

1.1

—

(44806071) Cardiolipin IgM antibody measurement

3.34

1.96

1.1

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

598

1.37

1.96

3.3

3.9

3.99

3.90

mmol/l

0.89

591

(40768800) Prostate Pathology biopsy report

485

0.61

1.94

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

4.55

1.94

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

197

2354

0.82

1.93

13.3

7.3

—

(3004616) Nuclear Ab [Presence] in Serum

250

1.57

1.93

1.4

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.45

1.93

1.1

—

(3014271) Vancomycin [Susceptibility]

1.93

1.90

3.4

2.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

193

2305

0.82

1.89

1.3

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

1.88

0.0

1.1

—

0.41

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

143

0.35

1.87

4.0

3.9

14.04

13.28

—

143

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.86

1.86

2.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

477

1.40

1.83

5.0

4.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.17

1.82

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

199

1.62

1.80

2.2

1.8

67.23

2835.06

u/l

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

185

1546

1.22

1.74

1.7

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

233

1.56

1.73

1.5

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

734

1.31

1.73

1.9

3.7

6.51

3.37

ratio

0.46

431

(3038515) Glucose [Moles/volume] in Venous blood

432

1.40

1.72

3.9

3.5

7.48

7.52

mmol/l

0.04

418

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

1.68

0.0

1.4

—

0.46

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1472

14226

1.13

1.67

63.4

22.5

15.14

13.75

130.54

1463

14042

(3052592) Norovirus Ag [Presence] in Stool

2.59

1.66

2.0

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.25

1.63

1.1

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

103

816

1.28

1.58

2.0

3.9

68.17

56.41

mg/l

0.28

704

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

421

0.64

1.55

1.3

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

176

1.60

1.55

1.4

1.3

2.57

2.90

g/l

0.46

130

(3027135) IgG subclass 1 [Mass/volume] in Serum

176

1.60

1.55

1.4

1.3

7.87

6.81

g/l

0.50

129

(3024139) IgG subclass 3 [Mass/volume] in Serum

176

1.60

1.55

1.4

1.3

0.43

0.39

g/l

0.19

128

(40762814) Titanium [Mass/volume] in Blood

0.00

1.52

0.0

2.4

—

3.24

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

302

3406

0.87

1.52

1.3

38.85

35.23

iu/ml

0.19

1088

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

209

1.54

1.51

1.1

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

453

0.66

1.50

2.2

1.8

42.70

42.21

nmol/l

0.04

431

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

135

1113

1.23

1.48

1.2

153.25

130.89

u/ml

0.18

407

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

251

1.48

1.3

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

550

1.32

1.46

1.2

1.3

4.49

8.08

u/ml

0.57

(3044290) Cell count panel - Cerebral spinal fluid

412

1.37

1.45

3.4

1.4

—

(3037756) Immunofixation for Serum or Plasma

517

1.33

1.43

1.5

1.7

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

133

1.66

1.42

1.7

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

111

1.72

1.39

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

101

814

1.25

1.38

2.0

3.9

33.98

80.02

mg/l

1.59

703

(3041096) Erythrocytes [Presence] in Urine by Automated

550

5080

1.11

1.37

4.4

3.6

0.22

0.19

estimate

0.04

231

1638

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

452

1.34

1.36

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

604

5609

1.11

1.36

4.6

4.3

0.00

estimate

0.01

236

1938

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.95

1.36

2.0

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

549

1.30

1.35

1.3

1.2

2.10

3.50

u/ml

—

(3024869) Neuronal Ab [Presence] in Serum

2.15

1.33

1.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

791

1.25

1.33

1.4

1.8

5.87

7.98

iu/ml

0.58

186

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.31

0.0

1.7

—

1.70

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

635

0.73

1.30

1.7

1.6

42.03

18.82

u/ml

—

113

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.10

1.30

1.1

1.5

—

(3025130) Human papilloma virus identified in Specimen

172

0.52

1.29

1.7

1.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.36

1.29

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.94

1.27

1.0

1.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1341

13806

0.91

1.14

5.8

4.6

21.79

13.13

mm/h

30.84

1244

12873

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

218

2458

0.87

1.12

3.7

5.3

29.66

32.92

4.75

157

1580

(3019150) Specific gravity of Urine by Refractometry

400

4341

0.90

1.09

4.9

4.3

1.02

1.36

kg/l

0.50

301

2916

(3030981) Hyaline casts [#/volume] in Urine by Automated count

198

1750

1.15

1.04

3.0

2.5

0.40

0.49

e6/l

0.27

192

1681

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

497

0.74

1.03

1.3

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.28

1.03

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.81

0.98

1.3

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.80

0.96

1.1

1.4

—

127.33

titre

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.95

0.0

1.3

—

65.47

—

(3004451) EKG impression Narrative

141

1.49

0.95

1.3

—

(3045424) Erythrocytes [Presence] in Urine

984

0.83

0.94

2.6

2.3

0.00

0.89

estimate

0.50

281

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1101

0.84

0.92

1.2

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

828

1.19

0.92

3.1

2.7

9.80

10.52

g/l

0.67

750

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

118

1.53

0.91

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

305

1.32

0.90

1.4

1.7

0.94

0.87

g/l

0.10

242

(3004716) Salmonella sp identified in Stool by Organism specific culture

729

1.20

0.90

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.75

0.90

1.0

—

(3022145) Colonoscopy Study observation

203

2258

0.89

0.88

1.3

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

161

1.43

0.86

1.7

2.0

1.55

1.67

u/field

0.04

(4034850) Laboratory test

581

0.79

0.86

14.0

11.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

213

1.37

0.84

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

105

1.53

0.81

1.4

1.7

—

(3049717) Cytology report of Urine Cyto stain

101

869

1.17

0.80

2.4

2.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

331

3567

0.91

0.80

1.7

1.5

2.33

2.59

g/l

1.84

241

2143

(3011985) Renin [Units/volume] in Plasma

268

1.31

0.79

1.8

1.4

29.57

78.66

mu/l

1.45

240

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.79

0.0

1.2

—

1.85

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.52

0.78

1.0

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.51

0.78

3.2

1.7

41.18

39.66

g/l

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

449

1.23

0.76

3.1

1.3

3.64

3.78

mmol/l

0.57

422

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

257

2361

1.10

0.74

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

277

0.72

0.73

1.3

0.66

7.16

nmol/l

0.50

262

(3024263) Appearance of Synovial fluid

106

0.56

0.72

1.8

1.6

—

(3017704) Immunofixation for Urine

142

1.41

0.72

1.4

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.61

0.72

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.58

0.71

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.93

0.70

1.0

2.6

41.00

44.61

umol/l

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1181

11508

1.06

0.70

5.5

3.4

96.47

53.27

u/l

10.48

1125

10721

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.55

0.69

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

488

5142

0.93

0.68

3.5

3.1

0.00

0.02

0.50

130

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

284

0.74

0.67

1.3

0.20

0.43

nmol/l

—

(3016018) Differential panel - Cerebral spinal fluid

232

1.30

0.66

3.1

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

115

1296

0.88

0.65

2.7

2.5

21.52

21.42

au/ml

—

106

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

962

1.14

0.65

3.0

2.6

3.52

3.75

g/l

0.75

103

888

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

962

1.14

0.65

3.0

2.6

4.03

4.20

g/l

1.83

103

889

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

962

1.14

0.65

3.0

2.6

7.81

7.40

g/l

1.21

103

888

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

588

1.18

0.64

1.5

35.53

12.18

iu/ml

0.28

100

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.73

0.64

1.2

1.0

—

(40768443) Skin Pathology biopsy report

102

898

1.14

0.63

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

924

9524

0.94

0.63

2.8

2.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

102

901

1.14

0.61

3.1

2.7

3.27

2.95

g/l

1.84

828

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1849

18336

1.11

0.60

45.5

13.3

26.55

25.54

u/l

2.11

1833

17799

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

89.90

—

(3000034) Microalbumin [Mass/volume] in Urine

174

1.33

0.60

2.4

3.3

26.91

30.49

mg/l

0.10

134

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.54

0.59

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.57

0.58

2.0

3.0

4.89

4.80

kpa

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.57

0.58

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.57

0.58

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.57

0.58

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.57

0.58

2.0

3.0

10.25

10.13

kpa

—

(3013637) Mi-2 Ab [Presence] in Serum

1.57

0.58

1.0

—

(3023410) Appearance of Cerebral spinal fluid

219

1.28

0.58

5.4

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

140

1.36

0.58

1.5

1.3

0.26

0.99

u/ml

0.86

(3000330) Specific gravity of Urine by Test strip

113

1009

1.13

0.58

4.0

3.6

1.02

ratio

0.59

107

929

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.51

0.56

2.1

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.46

0.56

1.3

98.50

104.06

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

636

1.15

0.54

3.1

2.7

0.00

g/l

-0.00

604

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

693

1.15

0.54

3.0

2.6

0.35

0.02

g/l

0.46

633

(3026470) Cobalt [Mass/volume] in Blood

147

0.68

0.53

2.4

2.3

4.38

3.06

ug/l

—

139

(3032773) Endomysium IgG Ab [Titer] in Serum

169

0.71

0.52

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

116

1048

1.11

0.51

2.5

2.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.39

0.50

1.0

2.4

15.62

142.65

ug/l

—

(4146454) Self-monitoring of blood glucose

246

0.77

0.49

2.5

2.6

—

(3025577) Chromium [Mass/volume] in Blood

144

0.69

0.49

2.4

2.2

2.03

1.88

ug/l

—

123

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

437

1.17

0.48

3.4

1.4

24.16

49.36

e6/l

0.46

318

(1617658) Protocol used for examination of sentinel lymph nodes

154

1.30

0.48

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.40

0.48

1.5

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

226

1.24

0.48

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

120

1.34

0.46

1.1

1.3

1.47

1.15

nmol/l

0.33

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.61

0.45

1.2

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

440

1.16

0.45

3.5

1.5

151.75

740.31

e6/l

1.15

337

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.43

0.45

1.5

100.00

82.56

umol/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

1.36

0.45

1.1

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

165

1.28

0.45

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

459

0.85

0.44

3.1

3.5

0.85

0.81

nmol/l

0.30

377

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

121

1.32

0.44

1.6

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

197

0.76

0.44

1.9

2.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.43

0.42

2.5

1.7

18.13

15.43

pmol/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

574

0.87

0.42

1.3

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.38

0.41

1.0

1.1

—

(4198724) Urine methamphetamine measurement

1.52

0.41

1.0

1.2

—

(3051339) Copper [Moles/volume] in Blood

0.00

0.41

0.0

1.3

—

17.15

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

1.4

—

(3001729) Color of Synovial fluid

0.00

0.41

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

1.39

0.40

1.6

1.2

—

77.45

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

103

0.68

0.39

1.1

1.2

—

(3016330) Potassium [Moles/time] in 24 hour Urine

0.00

0.39

0.0

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.39

0.0

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

495

1.14

0.38

2.2

2.3

94.44

102.33

ug/min

0.10

293

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.33

0.37

1.0

1.2

—

(3047189) Immunofixation for 24 hour Urine

114

0.70

0.37

1.4

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.36

0.36

1.2

275.89

212.37

iu/ml

0.25

(3002619) Bacteria identified in Specimen by Culture

1.43

0.35

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.36

0.34

1.5

1.1

18.95

16.72

umol/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

136

1.25

0.33

2.8

2.3

7.34

8.28

mmol/l

0.98

136

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

407

1.13

0.32

1.3

1.6

0.91

0.83

nmol/l

0.36

333

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.33

0.32

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

677

1.10

0.30

3.1

2.6

0.02

0.00

g/l

0.49

605

(3021960) Folate [Moles/volume] in Serum or Plasma

620

6049

1.04

0.30

1.9

1.7

17.43

20.32

nmol/l

6.37

569

5049

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

120

1.25

0.30

1.6

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.31

0.30

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

292

0.85

0.29

1.3

1.5

—

(44813793) Dust mix specific IgE antibody measurement

107

0.75

0.29

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1394

13796

1.03

0.28

8.1

4.5

15.24

14.94

pmol/l

4.02

1326

12570

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.29

0.28

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

116

0.77

0.27

1.2

1.6

84.44

90.93

umol/l

—

116

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

434

4217

1.04

0.27

1.7

1.8

29050766.63

24389978.19

pmol/l

0.06

358

3481

(3000764) Benzodiazepines [Presence] in Urine

289

0.86

0.26

1.3

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.26

0.26

2.2

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.67

0.25

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

224

0.85

0.25

1.0

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

120

1134

1.06

0.24

1.3

154.82

226.42

u/ml

0.95

1052

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

0.77

0.22

1.4

2.0

15.36

5.80

nmol/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1858

18510

1.05

0.22

66.4

24.2

87.42

80.10

umol/l

8.33

1841

18316

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.74

0.22

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

155

1481

1.05

0.22

2.3

11.07

13.14

nmol/l

2.75

145

1318

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

210

0.86

0.22

1.4

1.3

1.06

1.48

nmol/l

1.08

186

(3009261) Glucose [Presence] in Urine by Test strip

1012

9994

1.03

0.22

4.6

4.2

0.00

0.16

estimate

0.56

269

1997

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.21

0.0

1.8

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

0.02

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.03

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

364.92

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.3

—

(3006653) Thiamine [Moles/volume] in Blood

103

0.78

0.21

2.8

1.3

205.25

135.19

nmol/l

—

103

(3035611) Eosinophils/Leukocytes in Synovial fluid

0.00

0.20

0.0

1.1

—

0.43

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.20

0.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.20

0.0

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

221

1.13

0.20

1.4

1.1

—

(3028300) Cannabinoids [Presence] in Urine

292

0.89

0.20

1.3

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

228

0.88

0.19

1.3

1.2

—

nmol/l

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.13

0.18

1.3

1.5

0.38

0.35

ug/l

—

(3016879) Cocaine [Presence] in Urine

269

0.89

0.18

1.3

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

223

1.12

0.18

1.4

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.19

0.18

1.4

1.7

1596.57

546.10

nmol/24h

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.13

0.17

1.1

—

(44806420) Estimation of glomerular filtration rate

173

0.87

0.16

1.7

2.7

—

(3027944) Amphetamines [Presence] in Urine

288

0.90

0.16

1.3

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

990

9801

1.02

0.16

4.6

4.1

0.00

estimate

0.50

273

2104

(3044927) Protein electrophoresis panel - Urine

246

0.89

0.16

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

244

1.11

0.16

1.1

2.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.78

0.14

1.9

1.3

134.76

162.36

pmol/l

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

832

1.05

0.14

3.6

2.7

0.87

1.26

g/l

0.59

726

(3000963) Hemoglobin [Mass/volume] in Blood

1866

18697

0.97

0.10

74.0

27.9

123.85

134.09

g/l

136.61

1848

18493

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.11

0.09

1.6

1.3

1.18

100.84

mg/l

—

(3035350) Ketones [Presence] in Urine by Test strip

998

9917

1.01

0.09

4.6

4.1

0.02

3.73

estimate

1.57

280

2158

(3010813) Leukocytes [#/volume] in Blood

1866

18694

0.97

0.09

73.7

27.7

7.33

6.76

e9/l

2.81

1845

18243

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.06

0.09

1.2

1.1

—

(3022621) pH of Urine by Test strip

145

1485

0.97

0.09

3.1

2.8

6.05

6.03

0.11

122

1035

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.04

0.09

1.0

1.3

1.90

3.73

umol/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.04

0.09

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.04

0.09

4.2

7.6

7.42

5.24

kpa

—

(3026361) Erythrocytes [#/volume] in Blood

1866

18693

0.97

0.09

73.6

27.7

4.08

4.44

e12/l

127.62

1846

18238

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1866

18693

0.97

0.09

74.6

28.3

37.71

40.06

87.55

1846

18476

(3035941) MCH [Entitic mass]

1866

18692

0.97

0.09

73.3

27.6

30.71

30.44

5.51

1847

18484

(3051387) C reactive protein [Mass/volume] in Capillary blood

400

1.05

0.08

2.4

3.8

26.77

27.61

mg/l

0.05

270

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1866

18691

0.98

0.08

73.4

27.6

93.32

91.62

29.39

1848

18484

(3007461) Platelets [#/volume] in Blood

1866

18690

0.98

0.08

73.8

27.7

239.04

246.41

e9/l

3.77

1849

18305

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

174

0.92

0.07

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.87

0.07

1.1

1.3

152.43

173.57

mmol/24h

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

354

1.05

0.06

1.2

—

(3005570) Glucose [Moles/volume] in Urine

183

0.93

0.06

2.6

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.11

0.06

1.0

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

237

1.06

0.05

1.6

58.73

60.60

0.09

147

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

728

7314

0.99

0.05

4.9

4.1

0.11

estimate

0.02

236

1728

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

248

1.05

0.05

1.3

289.05

305.07

pmol/l

0.09

214

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

261

0.96

0.04

1.4

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

190

1.05

0.04

1.2

—

(3015736) pH of Urine

783

7858

0.99

0.04

4.0

3.6

6.30

6.25

0.60

448

4328

(40768797) Stomach Pathology biopsy report

283

2811

1.01

0.03

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

112

1.07

0.03

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

182

1835

0.99

0.03

1.6

1.7

1.55

0.00

152

1558

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

118

0.93

0.02

1.3

10.82

9.82

mmol/l

0.21

110

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

152

1.05

0.02

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1707

17058

1.00

0.01

50.9

17.9

74.80

76.87

ml/min/173m2

3.79

1666

15986

(3003327) Ova and parasites identified in Stool by Light microscopy

563

1.01

0.01

1.9

1.6

—

(3018333) Ribosomal P Ab [Presence] in Serum

145

1.03

0.00

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

175

0.97

0.00

1.5

21.57

31.23

—

106

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

111

0.99

0.00

2.5

2.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

415

1.01

0.00

1.2

59.50

56.24

u/ml

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.03

0.00

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.03

0.00

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

254

0.98

0.00

1.7

2.5

40.15

23.19

mg/l

1.01

(40757494) Bilirubin.total [Moles/volume] in Blood

102

0.98

0.00

2.2

2.1

—

39.30

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

148

1.01

0.00

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

128

1.02

0.00

1.5

1.9

83.62

110.29

ng/l

0.66

128

(3028707) Methadone [Presence] in Urine by Screen method

133

0.98

0.00

1.0

1.8

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

163

0.98

0.00

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

157

1.02

0.00

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

2.43

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

61.21

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.02

-0.00

1.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

5.3

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

281.63

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.56

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.00

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.89

-0.00

1.0

1.1

1128.86

1573.22

miu/ml

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.96

-0.00

1.1

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.89

-0.00

3.7

3.0

14.11

22.09

mu/l

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

2.67

—

(4211845) Urine protein measurement

0.94

-0.00

3.3

3.5

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

293.46

—

(3006462) Nitrate [Presence] in Urine

0.92

-0.00

3.6

3.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.92

-0.00

1.6

1.2

959.22

403.79

u/l

—

(3022689) Creatine [Moles/volume] in Urine

0.86

-0.00

1.2

1.5

6.80

7.10

mmol/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

87.33

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_L01XE – L01XE Protein kinase inhibitors

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

L01XE Protein kinase inhibitors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for L01XE Protein kinase inhibitors (RX_L01XE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints